Efficacy and Safety of the Recombinant Zoster Vaccine in Adults 50 Years of Age or Older

Cited in blog · The New England Journal of Medicine, 385, 220-232. · 2021

Canac-Marquis M et al. (2021). Efficacy and Safety of the Recombinant Zoster Vaccine in Adults 50 Years of Age or Older. *The New England Journal of Medicine*, 385, 220-232.